Bremner K - Search Results

1

The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening.

Mühlberger N, Heijnsdijk EA, Kurzthaler C, Iskandar R, Krahn MD, Bremner K, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U. Mühlberger N, et al. Among authors: bremner k. Value Health. 2014 Nov;17(7):A559. doi: 10.1016/j.jval.2014.08.1843. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201843 Free article. No abstract available.

2

Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis.

Alibhai SMH, Papadopoulos E, Mina DS, Ritvo P, Tomlinson G, Sabiston CM, Durbano S, Bremner KE, Chiarotto J, Matthew A, Warde P, O'Neill M, Culos-Reed SN. Alibhai SMH, et al. Among authors: bremner ke. J Geriatr Oncol. 2024 Jan;15(1):101646. doi: 10.1016/j.jgo.2023.101646. Epub 2023 Nov 15. J Geriatr Oncol. 2024. PMID: 37976654 Clinical Trial.

3

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G. Krahn MD, et al. Urology. 2002 Aug;60(2):258-63. doi: 10.1016/s0090-4295(02)01712-0. Urology. 2002. PMID: 12137823

4

Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.

Krahn M, Bremner KE, Tomlinson G, Ritvo P, Irvine J, Naglie G. Krahn M, et al. Qual Life Res. 2007 Apr;16(3):509-22. doi: 10.1007/s11136-006-9132-x. Epub 2006 Nov 8. Qual Life Res. 2007. PMID: 17091359

5

A review and meta-analysis of prostate cancer utilities.

Bremner KE, Chong CA, Tomlinson G, Alibhai SM, Krahn MD. Bremner KE, et al. Med Decis Making. 2007 May-Jun;27(3):288-98. doi: 10.1177/0272989X07300604. Epub 2007 May 14. Med Decis Making. 2007. PMID: 17502448 Review.

6

Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Bremner KE, Bayoumi AM, Sherman M, Krahn MD. Bremner KE, et al. Can J Gastroenterol. 2007 Aug;21(8):491-500. doi: 10.1155/2007/182383. Can J Gastroenterol. 2007. PMID: 17703248 Free PMC article. Review.

7

Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients.

Bremner KE, Tomlinson G, Krahn MD. Bremner KE, et al. Qual Life Res. 2007 Dec;16(10):1665-75. doi: 10.1007/s11136-007-9264-7. Epub 2007 Oct 3. Qual Life Res. 2007. PMID: 17912614

8

Healthcare costs associated with prostate cancer: estimates from a population-based study.

Krahn MD, Zagorski B, Laporte A, Alibhai SM, Bremner KE, Tomlinson G, Warde P, Naglie G. Krahn MD, et al. BJU Int. 2010 Feb;105(3):338-46. doi: 10.1111/j.1464-410X.2009.08758.x. Epub 2009 Jul 7. BJU Int. 2010. PMID: 19594734

9

Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy.

Krahn MD, Bremner KE, Tomlinson G, Naglie G. Krahn MD, et al. Among authors: bremner ke. Prostate Cancer Prostatic Dis. 2009;12(4):361-8. doi: 10.1038/pcan.2009.32. Epub 2009 Sep 1. Prostate Cancer Prostatic Dis. 2009. PMID: 19901935

10

Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?

Krahn M, Bremner KE, Tomlinson G, Luo J, Ritvo P, Naglie G, Alibhai SM. Krahn M, et al. BJU Int. 2011 Nov;108(10):1588-96. doi: 10.1111/j.1464-410X.2011.10127.x. Epub 2011 Mar 31. BJU Int. 2011. PMID: 21453344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters